Selection of DNA aptamers targeting PirAB toxin for potential biosensing applications in acute hepatopancreatic necrosis disease (AHPND)
- 1INRS - Centre Armand Frappier Santé Biotechnologie
Abstract
The timely detection of AHPND is one of the key factors to avoid the great economic losses that this disease entails for aquaculture. The use of aptamers as detection tools allows us to develop a method focused on the specific needs of the producer, such as simple and easy to use, ability to carry out a safe and rapid response field detection. Vibrio parahaemolyticus is currently known as the main causal agent of AHPND in shrimp cultures, however, it is not limited to this species as a transfer of virulence factors has been observed, including the genes encoding the PirAB binary toxin. The concern that this transfer implies has led us to focus our interest on the PirAB binary toxin as a ligand for the development of aptamers capable of identifying it in the field in early stages and avoiding advanced stages of the disease, giving the producer the ability to take preventive actions and reduce the risk of losses. In the present work we have optimized the SELEX (systematic evolution of ligands by exponential enrichment) aptamer development methodology to rapidly develop candidates capable of detecting both the PirAB complex and its subunits separately, obtaining candidates with a dissociation constant (Kd) of 65 to 700 nM for the PirB subunit and 1 to 3 uM for the PirAB complex. These aptamers provide the first step toward the development of a rapid detection method targeting the causative toxin of AHPND and aid in a new user-friendly approach to early disease detection.
Related
- Pharmaceutical Applications of Nucleic Acid Aptamers: Recent Advances and Future Perspectives in Therapeutics, Biosensing, Bioanalysis, and Process Analysis
- Selection and characterization of ssDNA aptamers targeting tick-borne encephalitis virus particles
- PP2A targeting: balancing anticancer potential and neurological risk.
- Engineering aptamer-based therapeutics for precision cancer immunotherapy: from molecular targeting to clinical applications
- Starship transposons mobilise via a circular intermediate with potential biotechnological applications
BibTeX
@misc{aguilarsanchez2026selection,
title = {{Selection of DNA aptamers targeting PirAB toxin for potential biosensing applications in acute hepatopancreatic necrosis disease (AHPND)}},
author = {V. Aguilar-Sanchez and R. McKay and A. Hernandez-Santoyo and S. A. Soto-Rodriguez and J. Perreault},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.14.758549},
url = {https://www.biorxiv.org/content/10.64898/2026.10.14.758549v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Selection of DNA aptamers targeting PirAB toxin for potential biosensing applications in acute hepatopancreatic necrosis disease (AHPND)
AU - V. Aguilar-Sanchez
AU - R. McKay
AU - A. Hernandez-Santoyo
AU - S. A. Soto-Rodriguez
AU - J. Perreault
PY - 2026
DA - 2026/10/14
PB - bioRxiv
DO - 10.64898/2026.10.14.758549
UR - https://www.biorxiv.org/content/10.64898/2026.10.14.758549v1
AB - The timely detection of AHPND is one of the key factors to avoid the great economic losses that this disease entails for aquaculture. The use of aptamers as detection tools allows us to develop a method focused on the specific needs of the producer, such as simple and easy to use, ability to carry out a safe and rapid response field detection. Vibrio parahaemolyticus is currently known as the main causal agent of AHPND in shrimp cultures, however, it is not limited to this species as a transfer of virulence factors has been observed, including the genes encoding the PirAB binary toxin. The concern that this transfer implies has led us to focus our interest on the PirAB binary toxin as a ligand for the development of aptamers capable of identifying it in the field in early stages and avoiding advanced stages of the disease, giving the producer the ability to take preventive actions and reduce the risk of losses. In the present work we have optimized the SELEX (systematic evolution of ligands by exponential enrichment) aptamer development methodology to rapidly develop candidates capable of detecting both the PirAB complex and its subunits separately, obtaining candidates with a dissociation constant (Kd) of 65 to 700 nM for the PirB subunit and 1 to 3 uM for the PirAB complex. These aptamers provide the first step toward the development of a rapid detection method targeting the causative toxin of AHPND and aid in a new user-friendly approach to early disease detection.
ER -